+ Filter
Loading...
CD19 & CD28
Loading...Anti-CD19 & CD28 Products
- anti-CD19 immunotoxin HD37 (scFv)-PE (AGTO-L047E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized V-kappa
- Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
- Anti-Human CD19 Recombinant Antibody (TAB-108CL) (TAB-108CL)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Antibody
- Application: FC, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1611CL-F(E)) (TAB-1611CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Depletion, FuncS
- Anti-Human CD28 Recombinant Antibody (TGN1412) (TAB-064LC)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, Stim
- Anti-Human CD19 Recombinant Antibody (TAB-431CQ)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1, κ
- Application: ELISA, IHC, FC, IP, IF, FuncS
- Anti-Human CD19 Recombinant Antibody scFv Fragment (HD37) (TAB-1620CL-S(P))
-
- Application: FuncS
-
- Derivation: Mouse
- Species Reactivity: canine
- Type: Mouse IgG1
- Application: WB, ELISA, FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1627CL) (TAB-1627CL)
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD28 Recombinant Antibody (TAB-065LC) (TAB-065LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG, κ
- Application: ELISA
- Anti-Human CD19 Recombinant Antibody (396) (TAB-1625CL)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: Depletion, ELISA
- Human Anti-CD19 Recombinant Antibody (TAB-1626CL) (TAB-1626CL)
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD28 Recombinant Antibody (TAB-066LC) (TAB-066LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG1
- Application: FC, IF, ELISA
- Anti-Human CD28 Recombinant Antibody (ChTN228) (TAB-068LC)
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ELISA, FC
- Anti-Human CD28 Recombinant Antibody (HuTN228) (TAB-069LC)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, FC
- Anti-Human CD28 Recombinant Antibody Fab Fragment (TGN1412) (TAB-064LC-F(E))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1612CL-S(P)) (TAB-1612CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1613CL-S(P)) (TAB-1613CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1614CL-S(P)) (TAB-1614CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1616CL-S(P)) (TAB-1616CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1617CL-S(P)) (TAB-1617CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1618CL-S(P)) (TAB-1618CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1614CL-F(E)) (TAB-1614CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1616CL-F(E)) (TAB-1616CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1617CL-F(E)) (TAB-1617CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1618CL-F(E)) (TAB-1618CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1619CL-F(E)) (TAB-1619CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Anti-Human CD19 Recombinant Antibody Fab Fragment (cHD37) (TAB-1621CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: FuncS
- Anti-Human CD28 Recombinant Antibody scFv Fragment (ChTN228) (TAB-068LC-S(P))
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: FC, ELISA
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1612CL-F(E)) (TAB-1612CL-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1613CL-F(E)) (TAB-1613CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: Depletion, FuncS
-
- Species Reactivity: Human, Non-Human Primates
- Type: Mouse IgG1
- Application: FC, IP, WB, IHC, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, FC, ICC, IF, FuncS
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, WB
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Anti-Human CD19 Recombinant Antibody scFv Fragment (cHD37) (TAB-1621CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: FuncS
- Human Anti-CD28 Recombinant Antibody; Fab Fragment (TAB-065LC-F(E)) (TAB-065LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD28 Recombinant Antibody; Fab Fragment (TAB-066LC-F(E)) (TAB-066LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Anti-Human CD28 Recombinant Antibody Fab Fragment (ChTN228) (TAB-068LC-F(E))
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: FC, ELISA
- Anti-Human CD28 Recombinant Antibody Fab Fragment (HuTN228) (TAB-069LC-F(E))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, ELISA
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1619CL-S(P)) (TAB-1619CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Anti-Human CD19 Recombinant Antibody scFv Fragment (396) (TAB-1625CL-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: Depletion, ELISA
- Human Anti-CD19 Recombinant Antibody scFv Fragment (TAB-1626CL-S(P)) (TAB-1626CL-S(P))
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD19 Recombinant Antibody scFv Fragment (TAB-1627CL-S(P)) (TAB-1627CL-S(P))
-
- Type: Fully human antibody
- Application: Depletion
- Anti-Human CD28 Recombinant Antibody scFv Fragment (TGN1412) (TAB-064LC-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC
- Human Anti-CD28 Recombinant Antibody; scFv Fragment (TAB-065LC-S(P)) (TAB-065LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-CD28 Recombinant Antibody; scFv Fragment (TAB-066LC-S(P)) (TAB-066LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Anti-Human CD28 Recombinant Antibody scFv Fragment (HuTN228) (TAB-069LC-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, ELISA
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1622CL-S(P)) (TAB-1622CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1623CL-S(P)) (TAB-1623CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody scFv Fragment (381) (TAB-1624CL-S(P))
-
- Application: FC, Inhib, ELISA
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
- Anti-CD19 immunotoxin HD37 (IgG)-RTA (AGTO-G076R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-Sap (AGTO-G076S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-DT (AGTO-L047D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD19 immunotoxin HD37 (IgG)-PAP (AGTO-G076P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-RTA (AGTO-L047R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-Sap (AGTO-L047S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
-
- Target: CD28
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Mouse
- Cytokine 1 Species: Human
- Molecule Class: IL2-IgG2a
-
- Target: CD28
- Species Reactivity: Human
- Cytokine 1: TNF
- Host: Mouse
- Cytokine 1 Species: Human
- Molecule Class: TNF-IgG2a
- anti-CD19 immunotoxin HD37 (scFv)-PAP (AGTO-L047P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD19 immunotoxin HD37 (IgG)-PE (AGTO-G076E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-DT (AGTO-G076D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1622CL-F(E)) (TAB-1622CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1623CL-F(E)) (TAB-1623CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody Fab Fragment (381) (TAB-1624CL-F(E))
-
- Application: FC, Inhib, ELISA
- Mouse Anti-CD19 Recombinant Antibody (TAB-1622CL) (TAB-1622CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody (TAB-1623CL) (TAB-1623CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody (381) (TAB-1624CL)
-
- Application: FC, Inhib, ELISA
- Anti-Human CD19 Recombinant Antibody Fab Fragment (HD37) (TAB-1620CL-F(E))
-
- Application: FuncS
- Humanized Anti-CD19 Antibody scFv Fragment (HPAB-0036LY-S(P)) (HPAB-0036LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: WB
- Humanized Anti-CD19 Recombinant Antibody; scFv Fragment (HPAB-0023LY-S(P)) (HPAB-0023LY-S(P))
-
- Species Reactivity: Human
- Type: scFv
- Application: WB
- Recombinant Humanized Anti-CD28 Single Domain Antibody (FAMAB-0321YC-VH) (FAMAB-0321YC-VH)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized VH
- Application: ELISA
- Recombinant Humanized Anti-CD28 Single Domain Antibody (FAMAB-0320YC-VH) (FAMAB-0320YC-VH)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized VH
- Application: ELISA
-
- Derivation: Mouse
- Species Reactivity: Canine
- Type: Mouse scFv
- Application: WB, ELISA, FuncS
-
- Derivation: Mouse
- Species Reactivity: canine
- Type: Mouse Fab
- Application: WB, ELISA, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG1 F(ab')2, κ
- Application: Agonist, Stim, Neu, FC
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1611CL-S(P)) (TAB-1611CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
-
- Targets: CD19 & CD28
- Type: Fab2
- Application: FuncS, Promising therapeutic agent
- Anti-CD19 (hBU12)-Mc-MMAF ADC (SGN-19A) (ADC-L034)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Host Species: Human
- Specificity: Human
- Type: Humanized antibody
- Classification: Fc glycosylation/Non fucosylated
- Glycosylation site: Asn297 in Fc region
-
- Host Species: Human
- Specificity: Human
- Type: Humanized antibody
- Classification: Fc glycosylation/Non fucosylated
- Glycosylation site: Asn297 in Fc region
- Anti-CD19 (hBU12)-mcMMAF ADC (ADC-017LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (hBU12)-Mc-MMAE ADC (ADC-019LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (huB4)-SPDB-DM4 ADC (ADC-020LCT)
-
- Target: CD19
- Linker: SPDB (N-succinimidyl 4-(2-pyridyldithio)butyrate)
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
- Anti-CD19 (clone hBU12)-vcPAB-MMAE ADC (ADC-150CL)
-
- Target: CD19
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (clone BU12)-MC-MMAF ADC (ADC-189CL)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (Denintuzumab)-Mc-MMAF ADC (ADC-175LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (clone huB4)-mc-MMAF ADC (ADC-045LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (clone B496)-SPP-DM1 ADC (ADC-181LZY)
-
- Target: CD19
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone B496)-MCC-DM1 ADC (ADC-182LZY)
-
- Target: CD19
- Linker: MCC (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone huB4)-SMCC-DM1 ADC (ADC-157LZY)
-
- Target: CD19
- Linker: SMCC (4-[N-maleimidomethyl] cyclohexane-1 carboxylhydrazide).
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone MDX1435)-vc-duocarmycin ADC (ADC-163LZY)
-
- Target: CD19
- Linker: VC (valine-citrulline)
- Drug: duocarmycin
-
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Classification: Fc glycosylation/Low fucosylated
- Glycosylation site: Asn297 in Fc region
- Glycoform (ratio): GN-GN-M-(M-GN)2
-
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Classification: Fc glycosylation/Low fucosylated
- Glycosylation site: Asn297 in Fc region
- Glycoform (ratio): GN-GN-M-(M-GN)2
-
- Host Species: Mouse
- Specificity: Human
- Type: Mouse antibody
- Classification: Fc glycosylation
- Glycosylation site: Fc region
- Glycoform (ratio): G2-NANA
- Chicken Anti-CD19 Polyclonal IgY (BRD-0100MZ)
-
- Species Reactivity: Human
- Type: Chicken antibody
- Application: WB
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: IHC-P
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
CD28 (Cluster of Differentiation 28) is one of the proteins expressed on T cells that provide co-stimulatory signals required for T cell activation and survival. T cell stimulation through CD28 in addition to the T-cell receptor (TCR) can provide a potent signal for the production of various interleukins (IL-6 in particular).


Rheumatoid Arthritis
Systemic Lupus Erythematosus
Primary Immunodeficiency
Allograft Rejection
Autoimmune Thyroid Disease
Graft-versus-Host Disease
Maturity Onset Diabetes of the Young
